Wedge Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-14,978
| Closed | -$248K | – | 514 |
|
|
2023
Q1 | $248K | Buy |
14,978
+1,175
| +9% | +$19.5K | ﹤0.01% | 373 |
|
|
2022
Q4 | $257K | Buy |
13,803
+3,783
| +38% | +$70.4K | ﹤0.01% | 370 |
|
|
2022
Q3 | $129K | Sell |
10,020
-6,696
| -40% | -$86.2K | ﹤0.01% | 395 |
|
|
2022
Q2 | $117K | Buy |
16,716
+852
| +5% | +$5.96K | ﹤0.01% | 402 |
|
|
2022
Q1 | $132K | Sell |
15,864
-5,371
| -25% | -$44.7K | ﹤0.01% | 414 |
|
|
2021
Q4 | $144K | Sell |
21,235
-2,345
| -10% | -$15.9K | ﹤0.01% | 405 |
|
|
2021
Q3 | $125K | Buy |
23,580
+6,114
| +35% | +$32.4K | ﹤0.01% | 398 |
|
|
2021
Q2 | $100K | Sell |
17,466
-10,497
| -38% | -$60.1K | ﹤0.01% | 391 |
|
|
2021
Q1 | $129K | Sell |
27,963
-160,973
| -85% | -$743K | ﹤0.01% | 520 |
|
|
2020
Q4 | $631K | Buy |
188,936
+64,735
| +52% | +$216K | 0.01% | 374 |
|
|
2020
Q3 | $369K | Sell |
124,201
-2,473
| -2% | -$7.35K | ﹤0.01% | 412 |
|
|
2020
Q2 | $585K | Buy |
+126,674
| New | +$585K | 0.01% | 347 |
|